nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—HTR2B—Raloxifene—osteoporosis	0.628	0.678	CbGbCtD
Triflupromazine—ABCB1—Ethinyl Estradiol—osteoporosis	0.126	0.136	CbGbCtD
Triflupromazine—ABCB1—Conjugated Estrogens—osteoporosis	0.0922	0.0995	CbGbCtD
Triflupromazine—ABCB1—Estradiol—osteoporosis	0.0809	0.0874	CbGbCtD
Triflupromazine—CHRM1—Signaling by GPCR—CNR2—osteoporosis	8.57e-05	0.00116	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	8.48e-05	0.00115	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CNR2—osteoporosis	8.46e-05	0.00115	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TLN1—osteoporosis	8.38e-05	0.00114	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—P4HB—osteoporosis	8.28e-05	0.00112	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PKM—osteoporosis	8.27e-05	0.00112	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—FDPS—osteoporosis	8.27e-05	0.00112	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—WNT1—osteoporosis	8.24e-05	0.00112	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PTHLH—osteoporosis	8.2e-05	0.00111	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GAPDH—osteoporosis	8.13e-05	0.0011	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—WNT1—osteoporosis	8.06e-05	0.00109	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MGLL—osteoporosis	8.03e-05	0.00109	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	8.03e-05	0.00109	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	7.97e-05	0.00108	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—WNT1—osteoporosis	7.96e-05	0.00108	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	7.92e-05	0.00107	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—RAP1A—osteoporosis	7.92e-05	0.00107	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MGLL—osteoporosis	7.86e-05	0.00106	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPD2—osteoporosis	7.84e-05	0.00106	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PGLS—osteoporosis	7.84e-05	0.00106	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LRP5—osteoporosis	7.84e-05	0.00106	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.76e-05	0.00105	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MGLL—osteoporosis	7.76e-05	0.00105	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LRP5—osteoporosis	7.67e-05	0.00104	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—P4HB—osteoporosis	7.67e-05	0.00104	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LRP5—osteoporosis	7.57e-05	0.00103	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LRP6—osteoporosis	7.5e-05	0.00102	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTH—osteoporosis	7.46e-05	0.00101	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PTHLH—osteoporosis	7.45e-05	0.00101	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LRP6—osteoporosis	7.34e-05	0.000994	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RAP1A—osteoporosis	7.33e-05	0.000993	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	7.29e-05	0.000988	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CNR2—osteoporosis	7.27e-05	0.000985	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LRP6—osteoporosis	7.24e-05	0.000981	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	7.24e-05	0.00098	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—P4HB—osteoporosis	7.23e-05	0.00098	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CALCA—osteoporosis	7.22e-05	0.000978	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—ADCY5—osteoporosis	7.21e-05	0.000977	CbGpPWpGaD
Triflupromazine—DRD1—Circadian rythm related genes—IL6—osteoporosis	7.2e-05	0.000976	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	7.2e-05	0.000975	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PNP—osteoporosis	7.17e-05	0.000972	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ATIC—osteoporosis	7.17e-05	0.000972	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NFATC1—osteoporosis	7.15e-05	0.000969	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DKK1—osteoporosis	7.09e-05	0.000961	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	7.07e-05	0.000958	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTH—osteoporosis	7.03e-05	0.000953	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	6.98e-05	0.000945	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—LEP—osteoporosis	6.94e-05	0.000941	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RAP1A—osteoporosis	6.91e-05	0.000937	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.9e-05	0.000936	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CNR2—osteoporosis	6.85e-05	0.000929	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—WNT1—osteoporosis	6.83e-05	0.000926	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—ADCY5—osteoporosis	6.8e-05	0.000922	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NFATC1—osteoporosis	6.74e-05	0.000914	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—DKK1—osteoporosis	6.69e-05	0.000906	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—POMC—osteoporosis	6.68e-05	0.000906	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FGA—osteoporosis	6.65e-05	0.000901	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CALCA—osteoporosis	6.56e-05	0.000888	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—ADCY5—osteoporosis	6.55e-05	0.000888	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—POMC—osteoporosis	6.54e-05	0.000887	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—POMC—osteoporosis	6.46e-05	0.000875	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—WNT1—osteoporosis	6.44e-05	0.000873	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	6.43e-05	0.000872	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CALCA—osteoporosis	6.42e-05	0.00087	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ENO1—osteoporosis	6.4e-05	0.000867	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	6.33e-05	0.000858	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TLN1—osteoporosis	6.33e-05	0.000858	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PSMA2—osteoporosis	6.31e-05	0.000855	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PSMA5—osteoporosis	6.31e-05	0.000855	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGA—osteoporosis	6.27e-05	0.000849	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TLN1—osteoporosis	6.19e-05	0.000839	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTHLH—osteoporosis	6.18e-05	0.000837	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—BMP2—osteoporosis	6.18e-05	0.000837	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—ADCY5—osteoporosis	6.18e-05	0.000837	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TLN1—osteoporosis	6.12e-05	0.000829	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CA2—osteoporosis	6.1e-05	0.000827	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—OXCT1—osteoporosis	6.1e-05	0.000827	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FGB—osteoporosis	6.05e-05	0.000819	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—POMC—osteoporosis	5.97e-05	0.000808	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MGLL—osteoporosis	5.94e-05	0.000805	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PSMA2—osteoporosis	5.84e-05	0.000791	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PSMA5—osteoporosis	5.84e-05	0.000791	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTHLH—osteoporosis	5.83e-05	0.00079	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—BMP2—osteoporosis	5.83e-05	0.00079	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—IGF1—osteoporosis	5.74e-05	0.000778	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGB—osteoporosis	5.7e-05	0.000773	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PSMA2—osteoporosis	5.51e-05	0.000746	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PSMA5—osteoporosis	5.51e-05	0.000746	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—P4HB—osteoporosis	5.46e-05	0.00074	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CALCA—osteoporosis	5.44e-05	0.000737	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—IL6—osteoporosis	5.44e-05	0.000737	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—P4HB—osteoporosis	5.34e-05	0.000724	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—IL6—osteoporosis	5.32e-05	0.000721	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTH—osteoporosis	5.31e-05	0.000719	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—POMC—osteoporosis	5.31e-05	0.000719	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—P4HB—osteoporosis	5.27e-05	0.000715	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RAP1A—osteoporosis	5.22e-05	0.000707	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTH—osteoporosis	5.2e-05	0.000704	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CNR2—osteoporosis	5.17e-05	0.000701	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	5.14e-05	0.000696	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CALCA—osteoporosis	5.13e-05	0.000695	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTH—osteoporosis	5.13e-05	0.000695	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP19A1—osteoporosis	5.12e-05	0.000693	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RAP1A—osteoporosis	5.11e-05	0.000692	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NFATC1—osteoporosis	5.09e-05	0.00069	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CNR2—osteoporosis	5.06e-05	0.000686	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—IDH2—osteoporosis	5.05e-05	0.000685	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—DKK1—osteoporosis	5.05e-05	0.000684	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.04e-05	0.000683	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	5.04e-05	0.000683	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	5.03e-05	0.000681	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—POMC—osteoporosis	5e-05	0.000678	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CNR2—osteoporosis	5e-05	0.000677	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NFATC1—osteoporosis	4.98e-05	0.000675	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	4.96e-05	0.000672	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DKK1—osteoporosis	4.94e-05	0.00067	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KL—osteoporosis	4.94e-05	0.000669	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	4.92e-05	0.000666	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DKK1—osteoporosis	4.88e-05	0.000661	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—WNT1—osteoporosis	4.86e-05	0.000659	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—POMC—osteoporosis	4.82e-05	0.000653	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—WNT1—osteoporosis	4.76e-05	0.000645	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP27A1—osteoporosis	4.75e-05	0.000644	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGA—osteoporosis	4.73e-05	0.000641	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6R—osteoporosis	4.7e-05	0.000637	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—WNT1—osteoporosis	4.7e-05	0.000637	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—ADCY5—osteoporosis	4.66e-05	0.000632	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.66e-05	0.000632	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KL—osteoporosis	4.66e-05	0.000631	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.65e-05	0.00063	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGA—osteoporosis	4.63e-05	0.000628	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ACP5—osteoporosis	4.62e-05	0.000626	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGA—osteoporosis	4.57e-05	0.00062	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	4.56e-05	0.000619	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—POMC—osteoporosis	4.54e-05	0.000616	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	4.51e-05	0.000611	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6R—osteoporosis	4.43e-05	0.000601	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTHLH—osteoporosis	4.4e-05	0.000596	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BMP2—osteoporosis	4.4e-05	0.000596	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.35e-05	0.00059	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.34e-05	0.000589	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTHLH—osteoporosis	4.31e-05	0.000583	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BMP2—osteoporosis	4.31e-05	0.000583	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGB—osteoporosis	4.31e-05	0.000583	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TPI1—osteoporosis	4.3e-05	0.000582	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	4.25e-05	0.000576	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BMP2—osteoporosis	4.25e-05	0.000576	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGB—osteoporosis	4.21e-05	0.000571	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ADCY5—osteoporosis	4.18e-05	0.000566	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GPX1—osteoporosis	4.17e-05	0.000565	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGB—osteoporosis	4.16e-05	0.000564	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PSMA2—osteoporosis	4.16e-05	0.000563	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PSMA5—osteoporosis	4.16e-05	0.000563	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PSMA5—osteoporosis	4.07e-05	0.000551	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PSMA2—osteoporosis	4.07e-05	0.000551	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—P4HB—osteoporosis	4.04e-05	0.000548	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	4.02e-05	0.000544	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	4.02e-05	0.000544	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GAPDH—osteoporosis	3.97e-05	0.000537	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CALCA—osteoporosis	3.87e-05	0.000525	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADCY5—osteoporosis	3.87e-05	0.000524	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—RAP1A—osteoporosis	3.86e-05	0.000523	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—MTHFR—osteoporosis	3.84e-05	0.000521	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CALCA—osteoporosis	3.79e-05	0.000514	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—POMC—osteoporosis	3.78e-05	0.000512	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SPP1—osteoporosis	3.74e-05	0.000507	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CALCA—osteoporosis	3.74e-05	0.000507	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—POMC—osteoporosis	3.7e-05	0.000501	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	3.65e-05	0.000495	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADCY5—osteoporosis	3.65e-05	0.000494	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SPP1—osteoporosis	3.53e-05	0.000478	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KL—osteoporosis	3.52e-05	0.000477	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KL—osteoporosis	3.44e-05	0.000466	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—POMC—osteoporosis	3.43e-05	0.000465	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KL—osteoporosis	3.4e-05	0.00046	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IRS2—osteoporosis	3.39e-05	0.000459	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—POMC—osteoporosis	3.36e-05	0.000455	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6R—osteoporosis	3.35e-05	0.000453	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—POMC—osteoporosis	3.31e-05	0.000449	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—LEP—osteoporosis	3.31e-05	0.000449	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	3.28e-05	0.000444	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	3.23e-05	0.000438	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IRS2—osteoporosis	3.19e-05	0.000433	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ESR1—osteoporosis	3.16e-05	0.000429	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LEP—osteoporosis	3.12e-05	0.000423	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ENO1—osteoporosis	3.12e-05	0.000423	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PSMA2—osteoporosis	3.08e-05	0.000417	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PSMA5—osteoporosis	3.08e-05	0.000417	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—POMC—osteoporosis	3.07e-05	0.000417	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ESR1—osteoporosis	2.98e-05	0.000404	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IRS1—osteoporosis	2.96e-05	0.000401	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—POMC—osteoporosis	2.85e-05	0.000386	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IRS1—osteoporosis	2.79e-05	0.000378	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6R—osteoporosis	2.78e-05	0.000376	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADCY5—osteoporosis	2.76e-05	0.000373	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1—osteoporosis	2.74e-05	0.000371	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	2.7e-05	0.000365	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—POMC—osteoporosis	2.68e-05	0.000364	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SPP1—osteoporosis	2.67e-05	0.000361	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	2.66e-05	0.000361	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6R—osteoporosis	2.62e-05	0.000355	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SPP1—osteoporosis	2.61e-05	0.000353	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1—osteoporosis	2.58e-05	0.00035	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SPP1—osteoporosis	2.58e-05	0.000349	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP19A1—osteoporosis	2.5e-05	0.000338	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS2—osteoporosis	2.41e-05	0.000327	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS2—osteoporosis	2.36e-05	0.00032	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—osteoporosis	2.36e-05	0.00032	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS2—osteoporosis	2.33e-05	0.000316	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—osteoporosis	2.31e-05	0.000313	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—osteoporosis	2.28e-05	0.000309	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ESR1—osteoporosis	2.25e-05	0.000305	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ESR1—osteoporosis	2.2e-05	0.000299	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ESR1—osteoporosis	2.18e-05	0.000295	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS1—osteoporosis	2.1e-05	0.000285	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—osteoporosis	2.09e-05	0.000284	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS1—osteoporosis	2.06e-05	0.000279	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ADCY5—osteoporosis	2.04e-05	0.000276	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS1—osteoporosis	2.03e-05	0.000275	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—osteoporosis	2.03e-05	0.000275	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—POMC—osteoporosis	2.03e-05	0.000275	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—POMC—osteoporosis	1.98e-05	0.000269	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.98e-05	0.000268	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—osteoporosis	1.97e-05	0.000268	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—POMC—osteoporosis	1.96e-05	0.000265	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—osteoporosis	1.95e-05	0.000264	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.93e-05	0.000262	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.91e-05	0.000259	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—osteoporosis	1.91e-05	0.000259	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.88e-05	0.000255	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—osteoporosis	1.88e-05	0.000254	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—osteoporosis	1.65e-05	0.000223	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	1.64e-05	0.000222	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—osteoporosis	1.55e-05	0.00021	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—osteoporosis	1.55e-05	0.00021	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—POMC—osteoporosis	1.5e-05	0.000203	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—osteoporosis	1.49e-05	0.000202	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—osteoporosis	1.46e-05	0.000198	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—osteoporosis	1.44e-05	0.000195	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—osteoporosis	1.24e-05	0.000168	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—osteoporosis	1.17e-05	0.000159	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—osteoporosis	1.17e-05	0.000158	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—osteoporosis	1.17e-05	0.000158	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—osteoporosis	1.15e-05	0.000155	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	1.14e-05	0.000155	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—osteoporosis	1.13e-05	0.000153	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	1.13e-05	0.000153	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—osteoporosis	8.81e-06	0.000119	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—osteoporosis	8.62e-06	0.000117	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—osteoporosis	8.51e-06	0.000115	CbGpPWpGaD
